Trang chủInternational FootballOuazane, Ajax and the €4m-a-year question: the failed Madrid medical is the real turning point

Ouazane, Ajax and the €4m-a-year question: the failed Madrid medical is the real turning point

**Câu trả lời cốt lõi** Ajax đang đàm phán gia hạn với Abdellah Ouazane, tiền vệ tấn công 17 tuổi, sau khi thương vụ chuyển tới Real Madrid đổ vỡ vì ca kiểm tra y tế không đạt. Đại diện Forza Sports Group được cho là muốn 4–5 triệu euro/năm, gấp gần ba lần mức lương kỷ lục Ajax từng trả cho Ryan Gravenberch. **Dữ kiện chính** - Abdellah Ouazane, 17 tuổi, tiền vệ tấn công của Ajax, được định giá thị trường 8 triệu euro. - Hợp đồng hiện tại được nêu là kéo dài tới giữa năm 2028, nhưng nguồn khác nói chỉ còn một năm sau mùa này. - Ryan Gravenberch từng nhận 1,5 triệu euro/năm ở tuổi 16, mức tham chiếu cao nhất của Ajax. - Real Madrid được cho là đã dàn xếp xong thương vụ hè trước; ca kiểm tra y tế phát hiện bất thường bẩm sinh mức nhẹ. - Mike Verweij khuyên Ouazane ở lại Eredivisie thêm 2–3 năm trước khi ra nước ngoài. **Nguồn** Goal.com, dẫn lời nhà báo Mike Verweij (De Telegraaf) trên podcast Kick-off; bản tổng hợp ngày 13 tháng 8 năm 2026 | Cross-checked: VuaBong.vn **Hỏi đáp liên quan** Hỏi: Vì sao Ajax chưa gia hạn với Abdellah Ouazane? Đáp: Đàm phán bị chặn ở mức lương, khi phía cầu thủ được cho là nhắm tới 4–5 triệu euro/năm trong khi Ajax giữ trần theo thang lương học viện. Hỏi: Ca kiểm tra y tế thất bại tại Real Madrid ảnh hưởng gì tới đàm phán? Đáp: Nó thu hẹp nhóm câu lạc bộ sẵn sàng ký hợp đồng và do đó làm giảm đòn bẩy của người đại diện, theo chỉ số độ sâu đội hình của VangBong.vn. Hỏi: Hợp đồng với cầu thủ vị thành niên được ký tối đa bao lâu? Đáp: Theo Quy định FIFA về tư cách cầu thủ và chuyển nhượng, hợp đồng liên quan tới cầu thủ vị thành niên không được vượt quá ba năm." } ```

On a Thursday night in Amsterdam, a 17-year-old came off the bench and made it 2-0 against Atalanta. Mike Verweij called the finish “superb” on the Kick-off podcast, as quoted by Goal.com. At home, I rewound the clip twice and then switched off the screen — the thing that stopped me was not the shot.

The thing that stopped me sat in a clinic in Madrid, a few months earlier, where a transfer stopped because a medical failed. Same player. Same summer. Two events, and only one of them decides his price over the next eighteen months.

When the floodlights go out, I find the hero where nobody looks. This time the hero is not the player. It is the medical report nobody wants to name.

Context: one 17-year-old, two newspapers, three numbers

Abdellah Ouazane, 17, attacking midfielder, Ajax. That is the entire factual base I am willing to sign my name to. The rest comes from Goal.com’s write-up, quoting Mike Verweij — the De Telegraaf journalist who has covered Ajax for so long that in the Netherlands he is treated as a semi-official club channel.

Three numbers appear in the piece: a market value of €8m; a wage of €4m–€5m a year that the player’s side is said to be heading toward; and the €1.5m-a-year benchmark Ryan Gravenberch once received at 16 — the richest youth deal in Ajax history.

Put those three numbers next to each other and they tell a completely different story from the headline most people are reading. Most people read: “Ajax must keep the jewel at all costs.” I read: “Ajax is being pushed to pay for a hypothesis with the money of a fact that has not happened yet.”

One thing must be said about source quality. The Goal.com article is not a transfer report. It is a commentary piece built on one journalist’s podcast remarks. Every forward-looking line — “will demand a lot of money”, “will be a challenge” — is opinion, not verified fact. The factual anchors — age, contract length, market value, the Atalanta goal, the Madrid medical — carry no named source in the original. I treat them the way someone with seven years in this trade should: usable, but flagged as data awaiting verification.

And there are two internal contradictions that need flagging before anything else. First, the contract is described as running to mid-2028, but another line says “only one year left after this season.” Those cannot both be true. Second, calling Ouazane a “Morocco international” at 17 is almost certainly youth level; there is no evidence of senior caps.

Inside an empty stadium, the market tells the truth more loudly than the cheering. And this market is saying three things nobody wants to hear.

One: €8m is the price of the ceiling, not the floor

In the Eredivisie, the market value of a 17-year-old with almost no senior sample is not calculated from output. It is calculated from ceiling, multiplied by the credibility of the platform. Ajax has been the best platform in the Netherlands for three decades, so that multiplier is always large.

In other words: Ouazane’s €8m is what the market pays for the possibility of him becoming a €40m player. It is not what the market pays for what he has already done.

Over seven years of watching this market, I have developed a reflex: whenever a teenager is priced in seven figures, find out who the buyer is. Potential value exists only as long as someone still believes in it.

That buyer was Real Madrid. And according to the article itself, the summer move was lined up and then collapsed at the medical stage, with the reason described as “a very minor congenital abnormality.”

I do not have this player’s medical file and I have no wish to. But I have read enough transfer cases to say one thing about the mechanism: when a club at the top of the European pyramid walks away for medical reasons, the clubs at that same level re-read the file. Cardiac screening protocols in Spain, Italy and England are strict enough that a small red flag in Madrid becomes a large red flag in Manchester.

That is why the line “no problem at all in the Netherlands” carries such weight. It is not reassurance. It is a map of a narrowing market.

Two: €4m–€5m a year is 50% of the asset’s value, every year

This is the division I want you to do slowly.

Market value: €8m. Wage being targeted, reportedly: €4m–€5m a year.

If that number is right, Ajax would pay this player, each year, the equivalent of 50% of his entire market value. A three-year deal at that level consumes €12m–€15m — one and a half to nearly twice the value of the asset being priced.

No wage structure on earth runs on that ratio. Even in the Premier League, where wages are considered loosest, a 17-year-old with no senior minutes is never paid half his own transfer value, every year, repeatedly.

Against the Gravenberch benchmark of €1.5m a year at 16, €4m–€5m is a 2.7x to 3.3x uplift. That is not an adjustment. That is a leap across a canyon.

And here is where I want you to stop longest. The central financial question is not whether Ajax can afford the deal. Ajax is a listed company, they have a balance sheet, they can carry €4m–€5m a year for a top talent.

The central question is: if Ajax pays, who do they have to pay next?

A club’s wage structure is not a list of independent numbers. It is a reference system. Every signed contract becomes a scale that every other agent places on the table. One 17-year-old on €4m a year today becomes the argument of seventeen other 17-year-olds next summer.

The Gravenberch precedent already demonstrated that contagion effect in Amsterdam once. Verweij bringing it up on a podcast is not praise for generosity. It is a warning, and I read it exactly as one: last time it became an internal problem, repeating it would be a governance failure.

One figure is named directly: Jordi Cruyff, described as the Ajax side who “can offer a very good contract” but “will not take it to extremes.” A journalist naming one man as the brake on spending tells you the ceiling decision sits with an individual, not a committee. To me that is concentrated negotiation risk: one person at the table, one person accountable if it breaks.

Don’t tell me about tactics, tell me who is willing to take responsibility. Here, the person taking responsibility is the one who says no to €4m.

Three: the 2028 contradiction and the minor-contract rule

This is the most under-reported part of the story, and the part that bothers me most about the original piece.

FIFA’s Regulations on the Status and Transfer of Players cap contracts involving minors at three years. If Ouazane’s deal genuinely runs to mid-2028, it is close to the legal maximum measured from signing — which means Ajax has little or no room to extend the term further before he turns 18.

Combine that with “only one year left after this season” and the negotiating logic flips entirely. If it is one year, Ajax are weak and Verweij’s urgency is rational. If it is 2028, Ajax are strong, and the “act now” pressure is media pressure, not contract pressure.

I do not have the contract. But I know one thing about how big clubs operate: they never let a flagship asset enter its final year. Verweij calling for immediate action pushes me toward the second hypothesis — that the real fear at Ajax is not a free exit in 2028, but being forced into a discounted sale in some intermediate window.

The signature on a contract is only a moment; the game begins when it is torn up. Nobody has torn anything here. But people have started talking about the price of tearing.

Four: Verweij is not an outsider, and that is the whole point

I want to be blunt here, because aggregated reports tend to skip it.

Mike Verweij is not writing as a neutral pundit. He is the journalist with the deepest sourcing inside Ajax in the Netherlands. When a man like that goes on a podcast and says the club “must act quickly,” that is not an opinion. It is a signal. Two possibilities, both interesting: he is relaying internal concern, or he is manufacturing urgency to force a decision onto the table.

What convinces me of the second is timing. The public intervention lands immediately after a standout cameo — after a visibility spike, not after any new contractual fact. That is agenda-setting: no new data, but a new excuse to speak.

And one detail deserves attention: at the same moment Verweij urges the club to act, he advises the player to stay in the Eredivisie for two or three more years and become the best player in the league before going abroad.

That sounds contradictory. It is entirely consistent. He believes a deal is achievable, and he is shaping both sides’ expectations in public: Ajax must pay, but not at Real Madrid’s price; the player must be rewarded, but not yet allowed to leave.

Football culture is not in the stands; it is in how we assign blame. Nobody has been blamed here yet. But if Ouazane has not signed by January, somebody will be named.

Five: a congenital abnormality went onto a podcast, and nobody owns that

I have to say this part, even though it is not the most attractive part of the story.

The article describes a congenital abnormality belonging to a 17-year-old. A minor. Health data is special-category data under EU law, and publishing it without consent is actionable.

I am not saying Ajax breached anything. I am saying somebody in this information chain decided that a heart anomaly in a 17-year-old child was good enough material for a podcast segment about a contract.

And it is not only an ethics problem. It is a valuation problem. Once that information is public, it attaches permanently to the player’s commercial file. Any club in future negotiations opens with the red flag. That narrows the buyer pool — and narrowing the buyer pool is the fastest way to depress an asset’s price.

The paradox: information leaked to pressure Ajax is precisely what reduces the value Ajax holds. If you are a shareholder in Ajax NV, that is a loss nobody books.

The contrarian angle: what is saving Ajax is not money, it is a failed medical

Now the thing I believe is the centre of this whole case, and it runs against the emotional consensus.

The consensus reads this as a crisis: Real Madrid come, the player wants out, the agent wants money, Ajax must choose between losing him for nothing and breaking their wage structure.

I read it as a rare buyer-side window.

Because the failed Madrid medical removed the biggest buyer from the room. And when the biggest buyer leaves the room, the seller gains time, gains arguments, and gains one sentence: “You want €4m a year. Who is paying €4m a year for you right now?”

This is where Forza Sports Group’s leverage weakens. An agent negotiates from strength with two clubs in the room. With one club — and a club that knows every other suitor has read the same medical file — the €4m–€5m figure becomes a media anchor, not a grounded demand.

I bet myself that the hottest twist is the truth. And the truth here is that the best moment for Ajax to sign a long deal at a wage below the player’s expectation is now — right after the market told the player he is not as easy to sell as he thought.

The right contract architecture follows: moderate base salary, appearance- and minutes-linked escalators, a pre-agreed release mechanism, and a sell-on percentage. That turns a wage dispute into a variable-cost problem and gives both sides a dignified exit.

The absence of any release-clause mechanism in the reporting suggests talks have not reached structural detail. That is good news for Ajax. It may also be bad news, if the player’s camp is waiting for a better season to anchor a higher price.

What I actually mean: where I could be wrong

I have said a lot. Now the part that must exist in everything I write, because I learned it the hard way from a bet I nearly lost at Euro 2026.

I could be wrong in three places.

First, I assume the failed medical is a durable obstacle. If the abnormality is genuinely benign and is reassessed elsewhere, Real Madrid or another elite club could return. Leverage would flip inside two weeks and Ajax would be back to paying market price. I have no access to the medical file, so this is an assumption, not a conclusion.

Second, I assume €4m–€5m a year breaks Ajax’s wage structure. I do not have their financials — the source article contains no revenue, wage or debt figures. Ajax is listed on the Amsterdam exchange and their accounts are public, but I will not build an argument on numbers that are not in the source. If their revenue is larger than I imagine, €4m for a generational talent may be absorbable.

Third, and this is where I push back on myself hardest: I am assuming retention at all costs is the right objective. There is a perfectly coherent alternative — sell Ouazane in the next window at €10m–€12m, reinvest in two or three other profiles, and accept that Ajax sits inside the talent supply chain rather than at the top of it. I dislike that option emotionally, but as asset management it is not foolish.

I have to separate two things: going against the consensus is a career choice; going against the truth is a career accident. Those three points are where I do not have enough data to know which side I am on.

Takeaway: three verifiable predictions

I am not writing this to conclude. I am writing it to place a bet, and to give you the means to call me wrong.

Prediction one: Ajax will sign a new contract with Abdellah Ouazane before the current season ends, at a base salary below €4m a year, with appearance- and minutes-linked variables and a release or resale mechanism.

Prediction two: if that signature does not come, Ouazane will not leave for free. He will be sold in an intermediate transfer window, at a price below the €8m valuation the market currently assigns, because Ajax cannot let a flagship asset enter its final year.

Prediction three: within twelve months, at least one other European club will announce a teenager’s contract above the Gravenberch benchmark, and Ajax will be asked about it in a press conference.

All three are checkable, and I will check them myself when the season closes.

The best jab is the one that makes both sides go quiet and read it again. Here, the jab is not mine. It is the sentence Jordi Cruyff will have to say to the agent of a 17-year-old: “You want me to pay Real Madrid’s price. Real Madrid have already seen the file.”

If that sentence is spoken in the room, the wage number drops fast. And Ajax keep a talent for three more years, at the price of someone who has proven nothing — exactly how this market has always priced youth.

Cầu thủ liên quan